cagrilintide news Combined GLP-1/amylin analog bests monotherapy for HbA1c drop, weight loss in diabetes Cagrilintide Peptide - 5mg

The injection itself takes just seconds

Mounjaro (tirzepatide) is an MHRA-licensed medication for type 2 diabetes and weight management, working as a dual GIP and GLP-1 receptor agonist

The diabetes arm REDEFINE 2, run in adults with type 2 diabetes, showed 13.7% weight loss against 3.4% on placebo at 68 weeks a smaller effect, consistent with the pattern that people with diabetes tend to lose somewhat less on these drugs

Olfactory Training: Repeatedly smelling specific scents can help retrain the olfactory system

Breakthrough in 2025: BPC-157 & Thymosin Alpha-1 Peptide Therapy Breakthrough in 2025: Functional medicine clinics are now using peptides to modulate immune overactivity , resulting in: Lowered inflammation without suppressing immunity, unlike conventional immunosuppressants